These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 35479)

  • 1. [Introductory words to the exchange of results on the clinical effects of bromperidol. Results of open and double blind research].
    Bures E; Pöldinger W
    Int Pharmacopsychiatry; 1978; 13 Suppl 1():45-52. PubMed ID: 35479
    [No Abstract]   [Full Text] [Related]  

  • 2. Double-blind- evaluation of bromperidol versus haloperidol treatment in chronic psychotic patients.
    Malfroid M; Hens L; Roosen P; Dom R
    Acta Psychiatr Belg; 1978; 78(1):147-54. PubMed ID: 347877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The use of bromperidol in an open study].
    Hucker H
    Int Pharmacopsychiatry; 1978; 13 Suppl 1():53-61. PubMed ID: 35480
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects and side-effects of bromperidol in comparison with other antipsychotic drugs.
    Woggon B
    Acta Psychiatr Belg; 1978; 78(1):155-72. PubMed ID: 347878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of a double blind study with bromperidol and perphenazine].
    Woggon B
    Int Pharmacopsychiatry; 1978; 13 Suppl 1():62-71. PubMed ID: 35481
    [No Abstract]   [Full Text] [Related]  

  • 6. Haloperidol for chronically hospitalized psychotics: a double-blind comparison with thiothixene and placebo; a follow-up open evaluation.
    Howard JS
    Dis Nerv Syst; 1974 Oct; 35(10):458-63. PubMed ID: 17894059
    [No Abstract]   [Full Text] [Related]  

  • 7. [Influence of diagnosis, hospital and sex on the effects of bromperidol].
    Woggon B; Fleischhauer J; Widmer A
    Int Pharmacopsychiatry; 1979; 14(4):213-27. PubMed ID: 42629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Open studies in comparison to controlled studies in testing of neuroleptics].
    Pajonk FG; Holzbach R; Naber D
    Fortschr Neurol Psychiatr; 2000 Jul; 68(7):313-20. PubMed ID: 10945157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind comparison of risperidone and haloperidol in schizophrenic and schizoaffective psychoses.
    Cesková E; Svestka J
    Pharmacopsychiatry; 1993 Jul; 26(4):121-4. PubMed ID: 7694306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary note on the antipsychotic efficacy of bromperidol.
    Bataille M
    Acta Psychiatr Belg; 1978; 78(1):173-9. PubMed ID: 347879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind comparison of haloperidol (Haldol) and thioridazine (Mellaril) in outpatient children.
    Claghorn JL
    Curr Ther Res Clin Exp; 1972 Dec; 14(12):785-9. PubMed ID: 4629817
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The therapeutic effects of lorazepam in psychotic patients treated with haloperidol: a double-blind study.
    Guz I; Moraes R; Sartoretto JN
    Curr Ther Res Clin Exp; 1972 Dec; 14(12):767-74. PubMed ID: 4629815
    [No Abstract]   [Full Text] [Related]  

  • 14. The AMDP system in international clinical trials: a double-blind comparison of fluperlapine and haloperidol.
    Woggon B; Linden M; Beckmann H; Krebs E; Küfferle B; Müller-Oerlinghausen B; Pflug B; Schied HW
    Psychopharmacol Bull; 1986; 22(1):47-51. PubMed ID: 2873619
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of hostile, suspicious patients. Trifluoperazine versus haloperidol.
    O'Brien CP; DiGiacomo JN; Webb W
    Dis Nerv Syst; 1974 Feb; 35(2):75-8. PubMed ID: 17894044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indication of an antipsychotic action of the opiate antagonist naloxone.
    Emrich HM; Cording C; Pirée S; Kölling A; von Zerssen D; Herz A
    Pharmakopsychiatr Neuropsychopharmakol; 1977 Sep; 10(5):265-70. PubMed ID: 30101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cis(Z)-clopenthixol and haloperidol in chronic schizophrenic patients--a double-blind clinical multicentre investigation.
    Heikkilä L; Laitinen J; Vartiainen H
    Acta Psychiatr Scand Suppl; 1981; 294():30-8. PubMed ID: 7041517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The behavioral toxicity of bromocriptine in patients with psychiatric illness.
    Perovich RM; Lieberman JA; Fleischhacker WW; Alvir J
    J Clin Psychopharmacol; 1989 Dec; 9(6):417-22. PubMed ID: 2574194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the efficacy of haloperidol decanoate].
    Alvarez JV; Li Gambi M
    Acta Psiquiatr Psicol Am Lat; 1986 Sep; 32(3):233-6. PubMed ID: 2884807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parenteral haloperidol in psychiatric emergencies. Double-blind comparison with chlorpromazine.
    Gerstenzang ML; Krulisky TV
    Dis Nerv Syst; 1977 Aug; 38(8):581-3. PubMed ID: 328243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.